Form 4: Elanco Director Paul Herendeen Receives Stock Award

Elanco Animal Health director Paul Herendeen received 18,169 shares of common stock as part of an annual equity award.

Summary

• Paul Herendeen, a director at Elanco Animal Health, received 18,169 shares of common stock on November 29, 2024.
• This stock grant was part of an annual equity award for non-employee members of the company's Board of Directors.
• Following this transaction, Mr. Herendeen beneficially owns 74,499 shares of Elanco common stock.
• The shares were granted at a price of $0.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction of a stock grant to a board member, which is generally positive for aligning interests but not a major market-moving event.

Positives

• The equity award aligns the interests of the non-employee directors with the company's performance.
• The grant of shares at $0 indicates a long-term incentive for the director.

Industry Context

Equity awards are a common practice for compensating board members in publicly traded companies, aligning their interests with shareholders.

Comparison to Industry Standards

• Granting stock to board members is a standard practice across the industry, with the amount and vesting schedules varying based on company size, performance, and board member roles.
• Companies like Zoetis and IDEXX Laboratories also use equity awards as part of their compensation packages for non-employee directors.
• The specific number of shares granted to Mr. Herendeen is within the typical range for board member compensation at companies of Elanco's size.

Stakeholder Impact

• The stock grant aligns the interests of the director with the shareholders.
• The grant does not have a direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Elanco, stock award, equity, director, Paul Herendeen, board of directors, share ownership